Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a cohort of Italian HIV-1 seropositive patients extensively treated with antiretroviral drugs

International Journal of Antimicrobial Agents

Volumn 18, Issue 6, 2001, Pages 519-523

  Re, M C ^a   Borderi, M ^a   Monari, P ^a   Bon, I ^a   Gorini, R ^a   Gibellini, D ^a   Verucchi, G ^a   Fortunato, L ^a   Chiodo, F ^a   La Placa, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Multiple dideoxynucleoside analogue resistant HIV 1 variants; Q151M complex HIV 1 viral load

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ANTIRETROVIRUS AGENT; DIDANOSINE; ENZYME INHIBITOR; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; BIOLOGICAL MONITORING; COMBINATION CHEMOTHERAPY; EVALUATION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; ITALY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRAL GENETICS; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE;

ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; DIDEOXYNUCLEOSIDES; DRUG RESISTANCE, MULTIPLE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; ITALY; MUTATION; VIRAL LOAD;

EID: 0035217586     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00440-X     Document Type: Article

References (23)

1. Clinical impact of anti retroviral resistance testing: Current problems and future directions
2. Resistance against reverse transcriptase inhibitors
3. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management. International AIDS Society-USA Panel
4. Incidence and impact of resistance against approved antiretroviral drugs
5. Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
6. Anti-human immunodeficiency virus drug combination strategies
7. Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapy
8. Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries
9. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy
10. Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: Incidence and association with other resistance mutations
11. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides
12. Single and multidrug resistance mutations to reverse transcriptase and protease inhibitors: Human immunodeficiency virus type 1-infected patients from two geographical areas in Spain. Spanish groups for antiretroviral resistance studies
13. Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI group
14. Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure
15. A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance
16. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors
17. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)
18. Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance
19. Sequence analysis of the HIV-1 protease coding region of 18 HIV-1-infected patients prior to HAART and possible implications on HAART
20. A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215
21. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
22. Presence of genotypic resistance to anti-retroviral drugs in a cohort of therapy naive HIV-1 infected Italian patients
23. Epidemiology of HIV-1 and emerging problems